23andMe is one of Silicon Valley’s latest unicorns – now valued at over $1B with over $491M in venture capital investment. While they provide a valuable service to consumers, should we be wary of handing over this immensely personal data?
genetics
23andMe… and my likelihood of going bald
23andMe pairs its database of genotypes with user-reported phenotypes to uncover new targets for drug discovery
23andme: The power of genetic correlations
Science brings you far, a ton of data brings you farther.
23andMe – DNA analytics and the future of personalized medicine
DNA analytics and the future of personalized medicine